CClinicalTrials.gg
Status unknownNCT03322111Updated Oct 26, 2017

Assessment of Cyclofusion Capabilities of Normal Subjects and Patients With 3D Dynamic Random-dot Stereograms

An interventional study of measurement of the cyclofusion in Cyclofusion Competence, sponsored by Cantonal Hospital of St. Gallen. Status unknown. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-26.

Sponsored by Cantonal Hospital of St. Gallen · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
12 Years and older
Sex
All
01

Study summary

With this study the investigator wants measure the individual cyclofusion competence from healthy subjects and patients suffering from Strabismus with a only binocularly visible threedimensional Landolt-C stimulus. For this the participant has to look at a 3-D monitor with shutter glasses. The participant is sitting in 2 meter distance in front of the monitor. On the monitor appears the Landolt-C stimulus as a dynamic Random-Dot Stimulus. As long as the participant can fuse the stimulus he will be able to see the Landolt C-ring threedimensional. The participant is then ask to tell in which direction the notch of the Landolt-C ring points out. Once a critical degree of cyclotorsion is reached the participant will no longer be able to see the Landolt C ring and the individual cyclofusion competence is reached.

02

Conditions studied

  • Cyclofusion Competence
03

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Visual acuity >0,4; Stereopsis

Exclusion criteria

Exclusion Criteria:

  • Visual acuity \<0,4; no Stereopsis
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Cyclofusion

    Diagnostic Test: measurement of the cyclofusion

Interventions

  • Diagnostic testmeasurement of the cyclofusion

    Measurement of the maximal cyclofusion competence with a dynamic 3-D Random-Dot Landolt-C stimulus

05

What researchers measure

Primary outcomes

  1. In- and excyclofusion competence in healthy individuals. Change in In- and excyclofusion competence in patients who need a strabismus surgery before and 6 month after surgery.

    The maximum in- and maximum excyclofusion competence will be measured with the described test set-up. The results will be documented in degree.

    Time frame: Once in healthy individuals. Before and 6 month after a (independent from the study) performed strabismus surgery.

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT03322111
Lead sponsor
Cantonal Hospital of St. Gallen
Responsible party
Prof. Dr. Veit Sturm (Prof. Dr., Cantonal Hospital of St. Gallen) — Principal investigator
First posted
Oct 26, 2017
Start date
Jan 2018 (estimated)
Primary completion
Apr 20, 2019 (estimated)
Completion
Apr 20, 2019 (estimated)
Last update
Oct 26, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion